Table 3. Overview of included studies that evaluated the effectiveness of aerobic exercise alone intervention.
| Study and subjects | Intervention | Measurements | Key outcomes | Mean change in percentage (absolute value change) pain | Mean change in percentage (absolute value change) disability | Key limitations |
|---|---|---|---|---|---|---|
| Kanitz
et al.
43
14 patients, Aged: 30-50 years |
|
|
|
Scale: VAS (100 mm)
After intervention (12 weeks): LG: −66.67% (−3.8) AG: −47.27% (−2.6) |
Scale: ODI (0-100)
After intervention (12 weeks): LG: −40.59% (−4.1) AG: −48% (−4.8) |
|
| Bello and Adeniyi
49
50 patients, Aged: 18-60 years |
|
|
|
Scale: VAS (0-10 cm)
After intervention (8 weeks): LSG: −59.4% (−3.8) WG: −32.8% (−2.2) |
Scale: ODI (0-100)
After intervention (8 weeks): LSG: −48.9% (−23.1) WG: −14.4% (−6.7) |
|
| Chulliyil
et al.
45
30 patients, Aged: 18-45 years |
|
|
|
Scale: NRS (0-10 point)
After intervention (4 weeks): At rest: TG: −80.1% (−2.94) SCG: −69.3% (−2.86) On activity: TG: −55.4% (−3.73) SCG: −45.3% (−3.2) |
Scale: ODI (0-100)
After intervention (4 weeks): TG: −53.8% (−24.53) SCG: −49.8% (−26.4) |
|
| Hurley
et al.
44
246 patients, Aged: 18-65 years |
|
|
|
Scale: NRS (0-10)
At 3 months: WG: −17.8% (−0.97) ECG: −7.6% (−0.43) UG: −19.3% (−1.16) At 6 months: WG: −20.9% (−1.14) ECG: −9.4% (−0.53) UG: −15.8% (−0.95) At 12 months: WG: −21.4% (−1.17) ECG: −11% (−0.62) UG: −18.1% (−1.09) |
Scale: ODI (0-100)
At 3 months: WG: −12.8% (−4.45) ECG: −13% (−4.95) UG: −18% (−5.98) At 6 months: WG: −19.8% (−6.89) ECG: −15.5% (−5.91) UG: −15.3% (−5.09) At 12 months: WG: −18.7% (−6.51) ECG: −21% (−8) UG: −14.8% (−4.91) |
|
| Eadie
et al.
58
60 patients, Aged: 18-70 years |
|
|
|
Scale: NRS (0-10)
At 3 months: WG: −12.1% (−0.68) SG: −12.9% (−0.68) PG: −32% (−1.96) At 6 months: WG: +1.79% (+0.1) SG: −18.9% (1) PG: −33.9% (−2.08) |
ODI (0-100)
At 3 months: WG: −9.4% (−3.35) SG: −22% (−7.14) PG: −27.3% (−9.06) At 6 months: WG: −6.9% (−2.47) SG: −6.2% (−2) PG: −16.7% (−5.53) |
|
| Shnayderman and Katz-Leurer
54
52 patients, Aged: 18-65 years |
|
|
|
Did not measure | Scale: ODI (0-100)
After intervention (6 weeks): EG: −34.3% (−11.8) CG: −30.6% (−8.4) |
|
| Murtezani
et al.
59
101 patients, Aged: 18-65 years |
|
|
|
Scale: VAS (0-10 cm)
After intervention (12 weeks): EG: −66.7% (−4) CG: −1.6% (−0.1) |
Scale: ODI (0-100)
After intervention (12 weeks): EG: −49% (−15.2) CG: −0.3% (−0.1) |
|
| Kell and Asmundson
56
27 patients, Aged: >18 years |
|
|
|
Scale: VAS (0-10 cm)
At 8 weeks: RT: −27.8% (−1.5) AT: −5.9% (−4.9) At 16 weeks: RT: −38.9% (−2.1) AT: −5.9% (−0.3) CG: −2% (−0.1) |
Scale: ODI (0-100)
At 8 weeks: RT: −30.2% (−12.2) AT: −4.3% (−1.7) At 16 weeks: RT: −40.1% (−16.2) AT: −9.8% (−3.9) CG: −0.2% (−0.1) |
|
| Chatzitheodorou
et al.
57
20 patients, Aged: 25-65 years |
|
|
|
Scale: MPQ (0-78)
After intervention (12 weeks): EG: −40.1% (−21.6) CG: −0.6% (−0.3) |
Scale: RMDQ (0-24)
After intervention (12 weeks): EG: −30.4% (−4.2) CG: −0.7% (−0.1) |
|